4-butyrolactone has been researched along with Bile Duct Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boonmars, T; Chusorn, P; Jongthawin, J; Khuntikeo, N; Loilome, W; Namwat, N; Puapairoj, A; Tassaneeyakul, W; Techasen, A; Thanan, R; Yongvanit, P | 1 |
1 other study(ies) available for 4-butyrolactone and Bile Duct Cancer
Article | Year |
---|---|
PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.
Topics: 4-Butyrolactone; Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Cyclooxygenase 2; Dinoprostone; Female; Humans; Intramolecular Oxidoreductases; Male; Middle Aged; Prostaglandin-E Synthases; Signal Transduction; Thiophenes | 2014 |